Novel Gene-Therapy Approach for Glaucoma

Controlling Eye Pressure in New Ways

Principal Investigator

Simon John, PhD

Columbia University

New York, NY, USA

About the Research Project

Program

National Glaucoma Research

Award Type

Bold Ideas initiatives

Award Amount

$1,000,000

Active Dates

March 31, 2021 - June 30, 2024

Grant ID

CG2020004

Acknowledgement

Part D of Joint Research Award for a Collaborative Interinstitutional Grant.

Co-Principal Investigator(s)

Krishnakumar Kizhatil, PhD, The Ohio State University

Goals

The project aims to develop and test resources for Schlemm’s canal specific targeting and expression of genes for gene therapy. Successful development of this targeted therapy will help control eye pressure more effectively and provide better treatment options for glaucoma patients.

Related Grants

National Glaucoma Research

Maldevelopment of Schlemm's Canal in Children with Glaucoma

Active Dates

July 01, 2026 - June 30, 2028

Principal Investigator

Revathi Balasubramanian, PhD

Current Organization

Columbia University

National Glaucoma Research

Novel Visualization of Aqueous Outflow: Uncovering Glaucoma Mechanisms and Therapeutic Targets

Active Dates

July 01, 2026 - June 30, 2028

Principal Investigator

Tyson Kim, MD, PhD

Current Organization

University of California, San Francisco

National Glaucoma Research

Developing New Drugs for Glaucoma

Active Dates

January 01, 2026 - December 31, 2027

Principal Investigator

Pete Williams, PhD

Current Organization

Karolinska Institutet

View All Grants